There were 1,510 press releases posted in the last 24 hours and 400,447 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Rhythm Pharmaceuticals Announces First Patients Dosed in Phase 2 Trial Evaluating Oral MC4R Agonist LB54640 in Hypothalamic Obesity

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image